{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:11:16Z","timestamp":1778875876600,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["SAF2017-89726-R"],"award-info":[{"award-number":["SAF2017-89726-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2020-119710RB-I00"],"award-info":[{"award-number":["PID2020-119710RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["GA101057548"],"award-info":[{"award-number":["GA101057548"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["SLT017\/20\/000090"],"award-info":[{"award-number":["SLT017\/20\/000090"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01-AI131568"],"award-info":[{"award-number":["P01-AI131568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ebiom.2023.104732","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T16:00:31Z","timestamp":1690387231000},"page":"104732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination"],"prefix":"10.1016","volume":"95","author":[{"given":"Clara","family":"Duran-Castells","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Prats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Oriol-Tordera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuska","family":"Llano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Ballana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edurne","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Mu\u00f1oz-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Brander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-8879","authenticated-orcid":false,"given":"Marta","family":"Ruiz-Riol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104732_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2016.02.001","article-title":"Which therapeutic strategy will achieve a cure for HIV-1?","volume":"18","author":"Cillo","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ebiom.2023.104732_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111864","article-title":"Romidepsin and metformin nanomaterials delivery on streptozocin for the treatment of Alzheimer\u2019s disease in animal model","volume":"141","author":"Zeng","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2023.104732_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2020.00823","article-title":"HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: safety, immunogenicity and effect on the viral reservoir (Study BCN02)","volume":"11","author":"Mothe","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104732_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fimmu.2020.00418","article-title":"In\u00a0vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&Kill clinical trial","volume":"11","author":"Ros\u00e1s-Umbert","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104732_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"L\u00e9tourneau","year":"2007","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104732_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004071","article-title":"Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing","volume":"10","author":"Wei","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2023.104732_bib7","article-title":"Gut microbiome signatures linked to HIV-1 reservoir size and viremia control","author":"Borgognone","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2023.104732_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103956","article-title":"Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome","volume":"78","author":"Oriol-Tordera","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104732_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","article-title":"Targeting the brain reservoirs: toward an HIV cure","volume":"7","author":"Marban","year":"2016","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104732_bib10","first-page":"1715","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ebiom.2023.104732_bib11","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000002264","article-title":"Perspective on potential impact of HIV central nervous system latency on eradication","volume":"33","author":"Chan","year":"2019","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104732_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/QAD.0000000000003121","article-title":"Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy","volume":"36","author":"Munoz-Moreno","year":"2022","journal-title":"AIDS"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2023.104732_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/prca.201400101","article-title":"Proteomics in the investigation of HIV-1 interactions with host proteins","volume":"9","author":"Li","year":"2015","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104732_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13365-015-0371-x","article-title":"Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients","volume":"22","author":"Calcagno","year":"2016","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.ebiom.2023.104732_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.12688\/f1000research.10651.1","article-title":"HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment","volume":"6","author":"Brew","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ebiom.2023.104732_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eclinm.2019.05.009","article-title":"Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)","volume":"11","author":"Mothe","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2023.104732_bib17","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.2000933","article-title":"TL1A-DR3 plasma levels are predictive of HIV-1 disease control, and DR3 co-stimulation boosts HIV-1-specific T-cell responses","volume":"205","author":"Oriol-Tordera","year":"2020","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104732_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/cid\/civ456","article-title":"Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy","volume":"61","author":"Mart\u00ednez-Bonet","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104732_bib19","doi-asserted-by":"crossref","first-page":"959261","DOI":"10.3389\/fnins.2022.959261","article-title":"Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease","volume":"16","author":"Liu","year":"2022","journal-title":"Front Neurosci"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104732_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274565","article-title":"Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis","volume":"17","author":"Ning","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104732_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1007229","article-title":"Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers","volume":"15","author":"Conway","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104732_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/vaccines9080867","article-title":"HIV in the brain: identifying viral reservoirs and addressing the challenges of an HIV cure","volume":"9","author":"Ash","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104732_bib23","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0214-17.2017","article-title":"MANF is essential for neurite extension and neuronal migration in the developing cortex","volume":"4","author":"Tseng","year":"2017","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104732_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00441-020-03287-6","article-title":"GDNF synthesis, signaling, and retrograde transport in motor neurons","volume":"382","author":"Cintr\u00f3n-Col\u00f3n","year":"2020","journal-title":"Cell Tissue Res"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104732_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/cells8090968","article-title":"Extracellular vesicles: a possible link between HIV and Alzheimer\u2019s disease-like pathology in HIV subjects?","volume":"8","author":"Kodidela","year":"2019","journal-title":"Cells"},{"issue":"6608","key":"10.1016\/j.ebiom.2023.104732_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.abk0637","article-title":"GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein","volume":"377","author":"Diaz-Ortiz","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104732_bib27","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-021-24077-w","article-title":"Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV","volume":"12","author":"Giron","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104732_bib28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkaa003","article-title":"Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption","volume":"75","author":"De Scheerder","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2023.104732_bib29","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"Hurst","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104732_bib30","article-title":"Gut microbiome signatures linked to HIV-1 reservoir size and viremia control","author":"Borgognone","year":"2021","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104732_bib31","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/JVI.01790-06","article-title":"Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2","volume":"81","author":"Kim","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104732_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10051260","article-title":"Siglec ligands","volume":"10","author":"Gonzalez-Gil","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104732_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1742-4690-10-154","article-title":"Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages","volume":"10","author":"Varchetta","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.ebiom.2023.104732_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-981-15-1580-4_8","article-title":"Siglecs at the host\u2013pathogen interface","volume":"1204","author":"Chang","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104732_bib35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104732_bib36","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","article-title":"Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease","volume":"96","author":"Ill\u00e1n-Gala","year":"2021","journal-title":"Neurology"},{"issue":"6175","key":"10.1016\/j.ebiom.2023.104732_bib37","first-page":"848","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"343","author":"Lee","year":"2013","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104732_bib38","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1093\/hmg\/ddv092","article-title":"Genetics of CD33 in Alzheimer\u2019s disease and acute myeloid leukemia","volume":"24","author":"Malik","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104732_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/13543784.2018.1452911","article-title":"Investigational CD33-targeted therapeutics for acute myeloid leukemia","volume":"27","author":"Walter","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104732_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI141965","article-title":"SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection","volume":"131","author":"Tsai","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104732_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168812","article-title":"Drug repositioning for Alzheimer\u2019s disease based on systematic \u201comics\u201d data mining","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104732_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001967","article-title":"Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity","volume":"3","author":"Rempel","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2023.104732_bib43","article-title":"Role of Siglecs in viral infections: a double-edged sword interaction","volume":"90","author":"Ra\u00efch-Regu\u00e9","year":"2022","journal-title":"Mol Aspects Med"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104732_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004146","article-title":"HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1","volume":"10","author":"Izquierdo-Useros","year":"2014","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104732_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024559","article-title":"Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids","volume":"6","author":"Zou","year":"2011","journal-title":"PLoS One"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:35:51Z","timestamp":1778873751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423002979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"alternative-id":["S2352396423002979"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104732","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104732"}}